Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Bladder cancer: oligometastases and imaging

Nature Reviews Urology volume 14, pages 513–514 (2017)Cite this article

Subjects

Abstract

The term oligometastases was introduced to describe patients with limited metastatic disease in whom treatment might result in long-term disease-free survival or even cure. Imaging is pivotal for identification of these patients. The definition of oligometastatic bladder cancer and the optimal imaging modalities for diagnosis and response prediction remain to be determined.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hellman, S. & Weichselbaum, R. R. Oligometastases. J. Clin. Oncol. 13, 8–10 (1995).

    Article  CAS  Google Scholar 

  2. Franklin, J. M., Sharma, R. A., Harris, A. L. & Gleeson, F. V. Imaging in oligometastatic cancer before local treatment. Lancet Oncol. 17, e406–e414 (2016).

    Article  Google Scholar 

  3. Witjes, A. et al. Updated 2016 EAU Guidelines on muscle-invasive and metastatic bladder cancer. Eur. Urol. 71, 462–475 (2017).

    Article  Google Scholar 

  4. Lehmann, J. et al. Surgery for metastatic urothelial carcinoma with curative intent: the German experience (AUO AB 30/05). Eur. Urol. 55, 1293–1299 (2009).

    Article  Google Scholar 

  5. Abe, T. et al. Outcome of metastasectomy for urothelial carcinoma: a multi-institutional retrospective study in Japan. J. Urol. 191, 932–936 (2014).

    Article  Google Scholar 

  6. Siefker-Radtke, A. O. et al. Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experience. J. Urol. 171, 145–148 (2004).

    Article  Google Scholar 

  7. Apolo, A. B. et al. Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancer. J. Clin. Oncol. 28, 3973–3978 (2010).

    Article  Google Scholar 

  8. Mertens, L. S. et al. Impact of 18F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle. BJU Int. 112, 729–734 (2013).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands

    Laura S. Mertens & Simon Horenblas

Authors
  1. Laura S. Mertens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Simon Horenblas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laura S. Mertens.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mertens, L., Horenblas, S. Bladder cancer: oligometastases and imaging. Nat Rev Urol 14, 513–514 (2017). https://doi.org/10.1038/nrurol.2017.96

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2017.96

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer